Effects of carbonic anhydrase inhibitors on potassium exchange in human red blood cells.
D000086:Acetazolamide / Q000494:pharmacology; D000328:Adult; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D002712:Chlorides / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006400:Hematocrit; D006461:Hemolysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006947:Hyperkalemia / Q000097:blood; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D010783:Photometry; D011188:Potassium / Q000097:blood*; D011194:Potassium Isotopes; D011868:Radioisotopes; D012964:Sodium / Q000097:blood; D013997:Time Factors
D002257:Carbonic Anhydrase Inhibitors; D002712:Chlorides; D011194:Potassium Isotopes; D011868:Radioisotopes; D012964:Sodium; D000086:Acetazolamide; D011188:Potassium